Sigma-2 receptor as potential indicator of stem cell differentiation

Molecular Imaging and Biology

Volumn 14, Issue 3, 2012, Pages 325-335

  Haller, Jodi L ^a   Panyutin, Irina ^a   Chaudhry, Aneeka ^a   Zeng, Chenbo ^b   Mach, Robert H ^b   Frank, Joseph A ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Amniotic fluid stem cell; Bone marrow stromal cells; Differentiation; EdU; Embryonic stem cell; Hematopoietic stem cell; Ki 67; Proliferation; Sigma 2 receptor

Indexed keywords

SIGMA 2 OPIATE RECEPTOR;

AMNIOTIC FLUID CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; EMBRYONIC STEM CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STEM CELL; STROMA CELL;

AMNIOTIC FLUID; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLUORESCENT DYES; HUMANS; PHENOTYPE; RATS; RECEPTORS, SIGMA; SPECTROMETRY, FLUORESCENCE; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861478911     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0493-3     Document Type: Article

References (40)

1. Cao F et al (2009) Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Res 69(7):2709-2713
2. Swijnenburg RJ et al (2008) In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev 17(6):1023-1029
3. Barberi T et al (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13(5):642-648 (Pubitemid 46828477)
4. Wang H, Chen X (2008) Imaging mesenchymal stem cell migration and the implications for stem cell-based cancer therapies. Future Oncol 4 (5):623-628
5. Pomper MG et al (2009) Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models. Cell Res 19 (3):370-379
6. Choi D et al (2008) Hepatocyte-like cells from human mesenchymal stem cells engrafted in regenerating rat liver tracked with in vivo magnetic resonance imaging. Tissue Eng Part C Methods 14(1):15-23 (Pubitemid 351520456)
7. Morgul MH et al (2008) Tracking of primary human hepatocytes with clinical MRI: initial results with Tat-peptide modified superparamagnetic iron oxide particles. Int J Artif Organs 31(3):252-257 (Pubitemid 351618703)
8. Leiker M et al (2008) Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells. Cell Transplant 17(8):911-922
9. Lee ES et al (2009) Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells 27(8):1921-1931
10. Toma C et al (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (1):93-98 (Pubitemid 34049148)
11. Jackson KA et al (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107(11):1395-1402 (Pubitemid 32522033)
12. Gallo P et al (2008) A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther 15(3):161-170 (Pubitemid 351150040)
13. Orban TI et al (2009) Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery. Stem Cells 27(5):1077-1087
14. Zhong, J.F., et al., A real-time pluripotency reporter for human stem cells. Stem Cells Dev. 19(1): p. 47-52.
15. Balakumaran, A., et al., Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". PLoS One. 5(7): p. e11462.
16. Martin WR et al (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197(3):517-532
17. Vangveravong S et al (2006) Synthesis of N-substituted 9-azabicyclo [3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands. Bioorg Med Chem 14(20):6988-6997 (Pubitemid 44307642)
18. Mach RH, Wheeler KT (2009) Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo. Cent Nerv Syst Agents Med Chem 9(3):230-245
19. Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124(2):195-206
20. Mach RH et al (1997) Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 57(1):156-161 (Pubitemid 27020346)
21. Wheeler KT et al (2000) Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 82(6):1223-1232 (Pubitemid 30128883)
22. Kashiwagi H et al (2009) Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma. J Transl Med 7:24
23. Mach RH, Dehdashti F, Wheeler KT (2009) PET Radiotracers for imaging the proliferative status of solid tumors. PET Clin 4(1):1-15
24. Scott RE, Wille JJ Jr, Wier ML (1984) Mechanisms for the initiation and promotion of carcinogenesis: a review and a new concept. Mayo Clin Proc 59(2):107-117 (Pubitemid 14193337)
25. Tzen CY et al (1988) Differentiation, cancer, and anticancer activity. Biochem Cell Biol 66(6):478-489
26. Orford KW, Scadden DT (2008) Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9(2):115-128
27. Flores, I. and M.A. Blasco, The role of telomeres and telomerase in stem cell aging. FEBS Lett. 584(17): p. 3826-30.
28. Dwyer, R.M. and M.J. Kerin, Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets? Hum Gene Ther. 21(11): p. 1506-12.
29. Zeng C et al (2007) Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res 67(14):6708-6716 (Pubitemid 47105517)
30. Kim, H.W., et al., Human Macrophage ATP7A is Localized in the trans-Golgi Apparatus, Controls Intracellular Copper Levels, and Mediates Macrophage Responses to Dermal Wounds. Inflammation.
31. Gehling UM et al (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95(10):3106-3112 (Pubitemid 30321161)
32. De Coppi P et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1):100-106 (Pubitemid 46087908)
33. Gerdes J et al (1984) Cell cycle analysis of a cell proliferation- associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710-1715 (Pubitemid 14035254)
34. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311-322 (Pubitemid 30054364)
35. Halfon, S., et al., Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging. Stem Cells Dev.
36. Ostenfeld MS et al (2008) Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation. Autophagy 4(4):487-499 (Pubitemid 351705145)
37. Groth-Pedersen L et al (2007) Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 67(5):2217-2225 (Pubitemid 46424241)
38. Crawford KW, Bowen WD (2002) Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 62(1):313-322 (Pubitemid 34074021)
39. Zeng C et al. Evaluation of 5-ethynyl-2?-deoxyuridine staining as a sensitive and reliable method for studying cell proliferation in the adult nervous system. Brain Res. 1319: p. 21-32.
40. Lin G et al (2009) Labeling and tracking of mesenchymal stromal cells with EdU. Cytotherapy 11(7):864-873